Metropolis Healthcare Schedules Q4FY26 Earnings Conference Call for May 14, 2026
Metropolis Healthcare Limited has scheduled its Q4FY26 earnings conference call for May 14, 2026 at 9:00 am IST, organized by Ambit Capital. The call will be attended by key company representatives including the Chairperson, Managing Director, and CFO, and will be moderated by Gaurav Tinani of Ambit Capital. The conference will cover financial results for the quarter ended March 31, 2026, with access available via primary Indian dial-in numbers and international toll-free lines for Singapore, Hong Kong, USA, and UK.
*this image is generated using AI for illustrative purposes only.
Metropolis Healthcare Limited has announced its Q4FY26 earnings conference call, scheduled for May 14, 2026 at 9:00 am (IST). The call has been organized by Ambit Capital and is being held pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The conference will focus on the company's financial results for the quarter ended March 31, 2026. The intimation was filed on May 07, 2026, and signed by Kamlesh C Kulkarni, Head – Legal & Secretarial.
Company Representatives
The earnings call will feature participation from senior leadership across key functional roles. The following representatives are scheduled to attend:
- Ms. Ameera Shah – Chairperson & Whole-time Director
- Mr. Surendran Chemmenkotil – Managing Director
- Mr. Sameer Patel – Chief Financial Officer
- Mr. Avadhut Joshi – Chief Business Development Officer
The teleconference will be moderated by Gaurav Tinani from Institutional Equities, Ambit Capital.
Conference Call Details
Investors and analysts can participate in the call through the following access details. Participants are requested to dial in a few minutes prior to the scheduled time, and may register via Diamond Pass to avoid wait time.
| Parameter: | Details |
|---|---|
| Date: | May 14, 2026 |
| Time: | 9:00 am (IST) |
| Organizer: | Ambit Capital |
| Primary Access Number 1: | +91 22 6280 1148 |
| Primary Access Number 2: | +91 22 7115 8049 |
| Singapore (Toll Free): | 800 101 2045 |
| Hong Kong (Toll Free): | 800 964 448 |
| USA (Toll Free): | 1 866 746 2133 |
| UK (Toll Free): | 0 808 101 1573 |
Regulatory Compliance
The intimation has been filed in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The disclosure was submitted to both BSE Limited and the National Stock Exchange of India Ltd. on May 07, 2026.
Historical Stock Returns for Metropolis Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +8.68% | +15.32% | +26.50% | +11.92% | +29.63% | -3.41% |
How might Metropolis Healthcare's Q4FY26 revenue growth compare to peers like Dr. Lal PathLabs and Thyrocare amid intensifying competition in the diagnostics sector?
Will management provide guidance on expansion plans or capital allocation strategy for FY27, particularly regarding new lab network additions or digital diagnostics investments?
How has the pricing pressure from aggregator platforms like Practo and PharmEasy impacted Metropolis Healthcare's margins, and what mitigation strategies might be discussed?
20
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
